申请人:TAISHO PHARMACEUTICAL CO., LTD
公开号:EP1854781A1
公开(公告)日:2007-11-14
A radioactive halogen-labeled phenyoxyaniline derivative represented by the following formula: wherein R1 represents a group such as an alkyl group; X1, X2, X3 and X4 represent each a hydrogen atom, an alkyl group, an alkoxy group, an alkoxy group carrying 11C introduced thereinto or a radioactive halogen atom, provided that at least one of X1, X2, X3 and X4 represents an alkoxy group carrying 11C introduced thereinto or a radioactive halogen atom; which is a compound useful as a PBR ligand having a high affinity and a high selectivity. In in vitro measurement of PBR, a PBR ligand having a high affinity and a high selectivity is labeled with a radioactive halogen nuclear species so as to enable the measurement of PBR in vivo with the use of means including not only PET but also SPECT. Thus, a compound which is useful in early diagnosing, preventing and treating diseases such as Alzheimer type dementia can be obtained.
一种放射性卤素标记的苯氧胺衍生物,其化学式如下:其中R1代表类似烷基的基团;X1、X2、X3和X4分别代表氢原子、烷基、烷氧基、携带11C的烷氧基或放射性卤素原子,至少其中之一代表携带11C的烷氧基或放射性卤素原子;该化合物作为具有高亲和力和高选择性的PBR配体而有用。在体外测量PBR时,将具有高亲和力和高选择性的PBR配体标记为放射性卤素核种,以便使用PET和SPECT等手段在体内测量PBR。因此,可以获得一种在早期诊断、预防和治疗阿尔茨海默型痴呆等疾病中有用的化合物。